| RESERVED AREA | LANGUAGE

Lung Cancer Study Group

Interview Prof. SUESH SENAN

At the “Round Table: Unpaid Surgical Stages”, Prof. SURESH SENAN explored the news in the combination of radiotherapy immunotherapy.

In his presentation, entitled “Immunotherapy + Radiotherapy: What’s New,” highlighted two major studies in which these two therapies “can improve the survival of lung cancer patients of no small inoperable cells, as well as cancer patients with cancer Small cell lung “. It also emphasized that this is a “significant advance, because the benefits are substantial, without increasing toxicity.”

The expert also addressed cases where this combination is more recommended and how it can contribute to maintaining the quality of life of patients, helping to prolong survival.

Get to know the key messages of Prof. SURESH SENAN Seeing the video.

Posted in congressos, entrevista, notícias, vídeo
©2022 Copyright GECP